ALTEN SAEO 1,05/ FR0000071946 /
| 2024-05-23 8:08:09 AM | Chg. +0.70 | Volume | Bid8:55:50 PM | Ask8:55:50 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 126.40EUR | +0.56% | 0 Turnover: 0.00 |
125.30Bid Size: 25 | 126.00Ask Size: 25 | 4.3 bill.EUR | 1.18% | 9.41 |
GlobeNewswire
11:23 PM
DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Se...
GlobeNewswire
11:22 PM
HRBR Stockholders: Robbins LLP Reminds HRBR Stockholders of Securities Fraud Class Action Against Ha...
GlobeNewswire
11:21 PM
INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against In...
GlobeNewswire
11:18 PM
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
Newsfile Corp
11:15 PM
American Aires Extends Global Expansion by Opening Latest International Fulfillment Center in the UK
GlobeNewswire
11:15 PM
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of ...
GlobeNewswire
11:13 PM
SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Onc...
GlobeNewswire
11:10 PM
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-10...
GlobeNewswire
11:09 PM
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant impr...
GlobeNewswire
11:06 PM
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (A...
GlobeNewswire
11:05 PM
Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
GlobeNewswire
11:05 PM
BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...
GlobeNewswire
11:05 PM
I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...
GlobeNewswire
11:05 PM
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...
GlobeNewswire
11:05 PM
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
11:05 PM
NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...
GlobeNewswire
11:05 PM
Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...
GlobeNewswire
11:04 PM
Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...
GlobeNewswire
11:03 PM
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...
